North America Quadriplegia Care Devices Market

Quadriplegia Care Devices Market: U.S. and Canada Industry Analysis and Forecast

North America Quadriplegia Care Devices Market Segmented By Stimulation Devices, Assistive Devices, Mobility Devices, Hospital Beds, Transfer Bench and Boards, Braces & Supports, Orthopaedic Splints Product with Incomplete, Complete Quadriplegia

- Table of Content -

1. Executive Summary

    1.1. North America Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion & Exclusion

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2.  Trends in Diverse Applications

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Increasing government support for the medical device sector

        4.1.2. Improved economic conditions leading to increased penetration by companies

        4.1.3. Rise in R&D spending

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Product Launches

        4.2.2. R&D expenditure by key players

        4.2.3. Degree of Technology advancements

        4.2.4. Adoption Rate

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

5. Market Context

    5.1. Emerging Technologies for Support & Care

    5.2. Regulatory Scenario

    5.3. PESTLE Analysis

    5.4. PORTERS Analysis

    5.5. Key Manufacturer’s Promotional Strategies

6. COVID19 Crisis Analysis

    6.1. Current GDP Projection and Probable Impact

    6.2. Current Economic Projection as compared to 2008 financial analysis

    6.3. COVID19 and Impact Analysis

        6.3.1. Revenue by Products

        6.3.2. Revenue by Indication

        6.3.3. Revenue by End User

        6.3.4. Revenue by Country

    6.4. 2020 Market Scenario

7. North America Quadriplegia Care Devices Market Demand (in Units) Analysis 2016-2020 and Forecast, 2021-2031

    7.1. Historical Market Volume (in Units) Analysis, 2016-2020

    7.2. Current and Future Market Volume (in Units) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

8. Quadriplegia Care Devices Market -Pricing Analysis

    8.1. Regional Pricing Analysis by Indication

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Average Pricing Analysis Benchmark

9. North America Quadriplegia Care Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. North America Quadriplegia Care Devices Market Analysis 2016-2020 and Forecast 2021-2031, by Products

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis and Volume in Units) By Products, 2016-2020

    10.3. Current and Future Market Size (US$ Mn) and Volume in Units) Analysis and Forecast by Products, 2021-2031

        10.3.1. Stimulation Devices

            10.3.1.1. Spinal cord Stimulators

            10.3.1.2. Functional Electrical Stimulation (FES) Systems

        10.3.2. Assistive Devices

            10.3.2.1. Exoskeletons

            10.3.2.2. Robotic Arm Systems

            10.3.2.3. Prosthetics

                10.3.2.3.1. Upper Limb Prosthetics

                10.3.2.3.2. Lower Limb Prosthetics

        10.3.3. Mobility Devices

            10.3.3.1. Wheelchairs

            10.3.3.2. Crutches & Walkers

            10.3.3.3. Gait Trainers

        10.3.4. Hospital Beds

        10.3.5. Transfer Bench and Boards

        10.3.6. Braces & Supports

        10.3.7. Orthopaedic Splints

        10.3.8. Others Supportive Devices

    10.4. Market Attractiveness Analysis by Products

11. North America Quadriplegia Care Devices Market Analysis 2016-2020 and Forecast 2021-2031, by Indication

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis by Indication, 2016-2020

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Indication, 2021 - 2031

        11.3.1. Incomplete quadriplegia

        11.3.2. Complete quadriplegia

    11.4. Market Attractiveness Analysis by Indication

12. North America Quadriplegia Care Devices Market Analysis 2016-2020 and Forecast 2021-2031, by End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis by End User, 2016-2020

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2021-2031

        12.3.1. Hospitals

        12.3.2. Rehabilitation Centres

        12.3.3. Assistive Living Facilities

        12.3.4. Long Term Care Centres

        12.3.5. Home Care Settings

    12.4. Market Attractiveness Analysis by End User

13. US Quadriplegia Care Devices Market Analysis 2016-2020 and Forecast 2021-2031

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    13.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031

        13.3.1. By Products

        13.3.2. By Indication

        13.3.3. By End User

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Canada Quadriplegia Care Devices Market Analysis 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    14.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031

        14.3.1. By Products

        14.3.2. By Indication

        14.3.3. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Competition Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Competition Deep Dive

        15.3.1. ReWalk Robotics

            15.3.1.1. Overview

            15.3.1.2. Product Portfolio

            15.3.1.3. Key Financials

            15.3.1.4. Recent Developments

            15.3.1.5. Sales Footprint

            15.3.1.6. Strategy Overview

                15.3.1.6.1. Marketing Strategy

                15.3.1.6.2. Product Strategy

                15.3.1.6.3. Channel Strategy

        15.3.2. Ekso Bionics

            15.3.2.1. Overview

            15.3.2.2. Product Portfolio

            15.3.2.3. Key Financials

            15.3.2.4. Recent Developments

            15.3.2.5. Sales Footprint

            15.3.2.6. Strategy Overview

                15.3.2.6.1. Marketing Strategy

                15.3.2.6.2. Product Strategy

                15.3.2.6.3. Channel Strategy

        15.3.3. Indego (Parker Hannifin Corporation)

            15.3.3.1. Overview

            15.3.3.2. Product Portfolio

            15.3.3.3. Key Financials

            15.3.3.4. Recent Developments

            15.3.3.5. Sales Footprint

            15.3.3.6. Strategy Overview

                15.3.3.6.1. Marketing Strategy

                15.3.3.6.2. Product Strategy

                15.3.3.6.3. Channel Strategy

        15.3.4. Rex Bionics Ltd.

            15.3.4.1. Overview

            15.3.4.2. Product Portfolio

            15.3.4.3. Key Financials

            15.3.4.4. Recent Developments

            15.3.4.5. Sales Footprint

            15.3.4.6. Strategy Overview

                15.3.4.6.1. Marketing Strategy

                15.3.4.6.2. Product Strategy

                15.3.4.6.3. Channel Strategy

        15.3.5. Caltech

            15.3.5.1. Overview

            15.3.5.2. Product Portfolio

            15.3.5.3. Key Financials

            15.3.5.4. Recent Developments

            15.3.5.5. Sales Footprint

            15.3.5.6. Strategy Overview

                15.3.5.6.1. Marketing Strategy

                15.3.5.6.2. Product Strategy

                15.3.5.6.3. Channel Strategy

        15.3.6. Össur

            15.3.6.1. Overview

            15.3.6.2. Product Portfolio

            15.3.6.3. Key Financials

            15.3.6.4. Recent Developments

            15.3.6.5. Sales Footprint

            15.3.6.6. Strategy Overview

                15.3.6.6.1. Marketing Strategy

                15.3.6.6.2. Product Strategy

                15.3.6.6.3. Channel Strategy

        15.3.7. Steeper, Inc.

            15.3.7.1. Overview

            15.3.7.2. Product Portfolio

            15.3.7.3. Key Financials

            15.3.7.4. Recent Developments

            15.3.7.5. Sales Footprint

            15.3.7.6. Strategy Overview

                15.3.7.6.1. Marketing Strategy

                15.3.7.6.2. Product Strategy

                15.3.7.6.3. Channel Strategy

        15.3.8. Boston Scientific corporation

            15.3.8.1. Overview

            15.3.8.2. Product Portfolio

            15.3.8.3. Key Financials

            15.3.8.4. Recent Developments

            15.3.8.5. Sales Footprint

            15.3.8.6. Strategy Overview

                15.3.8.6.1. Marketing Strategy

                15.3.8.6.2. Product Strategy

                15.3.8.6.3. Channel Strategy

        15.3.9. Medtronic Plc.

            15.3.9.1. Overview

            15.3.9.2. Product Portfolio

            15.3.9.3. Key Financials

            15.3.9.4. Recent Developments

            15.3.9.5. Sales Footprint

            15.3.9.6. Strategy Overview

                15.3.9.6.1. Marketing Strategy

                15.3.9.6.2. Product Strategy

                15.3.9.6.3. Channel Strategy

        15.3.10. Ottobock

            15.3.10.1. Overview

            15.3.10.2. Product Portfolio

            15.3.10.3. Key Financials

            15.3.10.4. Recent Developments

            15.3.10.5. Sales Footprint

            15.3.10.6. Strategy Overview

                15.3.10.6.1. Marketing Strategy

                15.3.10.6.2. Product Strategy

                15.3.10.6.3. Channel Strategy

        15.3.11. RGK Wheelchairs

            15.3.11.1. Overview

            15.3.11.2. Product Portfolio

            15.3.11.3. Key Financials

            15.3.11.4. Recent Developments

            15.3.11.5. Sales Footprint

            15.3.11.6. Strategy Overview

                15.3.11.6.1. Marketing Strategy

                15.3.11.6.2. Product Strategy

                15.3.11.6.3. Channel Strategy

        15.3.12. Rifton Equipment

            15.3.12.1. Overview

            15.3.12.2. Product Portfolio

            15.3.12.3. Key Financials

            15.3.12.4. Recent Developments

            15.3.12.5. Sales Footprint

            15.3.12.6. Strategy Overview

                15.3.12.6.1. Marketing Strategy

                15.3.12.6.2. Product Strategy

                15.3.12.6.3. Channel Strategy

        15.3.13. Allard USA, Inc.

            15.3.13.1. Overview

            15.3.13.2. Product Portfolio

            15.3.13.3. Key Financials

            15.3.13.4. Recent Developments

            15.3.13.5. Sales Footprint

            15.3.13.6. Strategy Overview

                15.3.13.6.1. Marketing Strategy

                15.3.13.6.2. Product Strategy

                15.3.13.6.3. Channel Strategy

        15.3.14. Fillauer LLC

            15.3.14.1. Overview

            15.3.14.2. Product Portfolio

            15.3.14.3. Key Financials

            15.3.14.4. Recent Developments

            15.3.14.5. Sales Footprint

            15.3.14.6. Strategy Overview

                15.3.14.6.1. Marketing Strategy

                15.3.14.6.2. Product Strategy

                15.3.14.6.3. Channel Strategy

        15.3.15. College Park Industries

            15.3.15.1. Overview

            15.3.15.2. Product Portfolio

            15.3.15.3. Key Financials

            15.3.15.4. Recent Developments

            15.3.15.5. Sales Footprint

            15.3.15.6. Strategy Overview

                15.3.15.6.1. Marketing Strategy

                15.3.15.6.2. Product Strategy

                15.3.15.6.3. Channel Strategy

        15.3.16. Mobius Bionics.

            15.3.16.1. Overview

            15.3.16.2. Product Portfolio

            15.3.16.3. Key Financials

            15.3.16.4. Recent Developments

            15.3.16.5. Sales Footprint

            15.3.16.6. Strategy Overview

                15.3.16.6.1. Marketing Strategy

                15.3.16.6.2. Product Strategy

                15.3.16.6.3. Channel Strategy

        15.3.17. Parker Hannifin

            15.3.17.1. Overview

            15.3.17.2. Product Portfolio

            15.3.17.3. Key Financials

            15.3.17.4. Recent Developments

            15.3.17.5. Sales Footprint

            15.3.17.6. Strategy Overview

                15.3.17.6.1. Marketing Strategy

                15.3.17.6.2. Product Strategy

                15.3.17.6.3. Channel Strategy

        15.3.18. Nevro

            15.3.18.1. Overview

            15.3.18.2. Product Portfolio

            15.3.18.3. Key Financials

            15.3.18.4. Recent Developments

            15.3.18.5. Sales Footprint

            15.3.18.6. Strategy Overview

                15.3.18.6.1. Marketing Strategy

                15.3.18.6.2. Product Strategy

                15.3.18.6.3. Channel Strategy

        15.3.19. ProBed Medical Technologies Inc.

            15.3.19.1. Overview

            15.3.19.2. Product Portfolio

            15.3.19.3. Key Financials

            15.3.19.4. Recent Developments

            15.3.19.5. Sales Footprint

            15.3.19.6. Strategy Overview

                15.3.19.6.1. Marketing Strategy

                15.3.19.6.2. Product Strategy

                15.3.19.6.3. Channel Strategy

        15.3.20. BLUE CHIP MEDICAL

            15.3.20.1. Overview

            15.3.20.2. Product Portfolio

            15.3.20.3. Key Financials

            15.3.20.4. Recent Developments

            15.3.20.5. Sales Footprint

            15.3.20.6. Strategy Overview

                15.3.20.6.1. Marketing Strategy

                15.3.20.6.2. Product Strategy

                15.3.20.6.3. Channel Strategy

        15.3.21. Restorative Therapies

            15.3.21.1. Overview

            15.3.21.2. Product Portfolio

            15.3.21.3. Key Financials

            15.3.21.4. Recent Developments

            15.3.21.5. Sales Footprint

            15.3.21.6. Strategy Overview

                15.3.21.6.1. Marketing Strategy

                15.3.21.6.2. Product Strategy

                15.3.21.6.3. Channel Strategy

        15.3.22. MYOLYN, LLC

            15.3.22.1. Overview

            15.3.22.2. Product Portfolio

            15.3.22.3. Key Financials

            15.3.22.4. Recent Developments

            15.3.22.5. Sales Footprint

            15.3.22.6. Strategy Overview

                15.3.22.6.1. Marketing Strategy

                15.3.22.6.2. Product Strategy

                15.3.22.6.3. Channel Strategy

16. Assumptions and Acronyms Used

17. Research Methodology

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

- List Of Table -

Table 01 (A): North America Quadriplegia Care Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 01 (B): North America Quadriplegia Care Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 02 (A): North America Quadriplegia Care Devices Market Volume (Unit) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 02 (B): North America Quadriplegia Care Devices Market Volume (Unit) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 03: North America Quadriplegia Care Devices Market Volume (Unite) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 04: North America Quadriplegia Care Devices Market Size Analysis (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 05: North America Quadriplegia Care Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 06 (A): U.S Quadriplegia Care Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 06 (B): U.S Quadriplegia Care Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 07 (A): U.S Quadriplegia Care Devices Market Volume (Unit) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 07 (B): U.S Quadriplegia Care Devices Market Volume (Unit) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 08: U.S Quadriplegia Care Devices Market Volume (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 09: U.S Quadriplegia Care Devices Market Size Analysis (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 10 (A): Canada Quadriplegia Care Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 10 (B): Canada Quadriplegia Care Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 11 (A): Canada Quadriplegia Care Devices Market Volume (Unit) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 11 (B): Canada Quadriplegia Care Devices Market Volume (Unit) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 12: Canada Quadriplegia Care Devices Market Volume (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 13: Canada Quadriplegia Care Devices Market Size Analysis (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

Figure 01: North America Quadriplegia Care Devices Market Historical Market (US$ Mn) Analysis, 2016-2020

Figure 02: North America Quadriplegia Care Devices Market Value (US$) & Y-o-Y Growth (%), 2021-2031

Figure 03: North America Quadriplegia Care Devices Market Absolute $ Opportunity, 2020-2031

Figure 04: Quadriplegia Care Devices Market Average Pricing Analysis, by Product Type, 2020 

Figure 05: Quadriplegia Care Devices Market Average Pricing Analysis, By Product Type, 2031

Figure 06: North America Quadriplegia Care Devices Market Historical Market (Unit) Analysis, 2016-2020

Figure 07: North America Quadriplegia Care Devices Market Volume (Unit) & Y-o-Y Growth (%), 2021-2031

Figure 08: North America Quadriplegia Care Devices Market Share Analysis (%) By Product Type, 2021 & 2031

Figure 09: North America Quadriplegia Care Devices Market Y-o-Y Growth (%) By Product Type, 2021-2031

Figure 10: North America Quadriplegia Care Devices Market Attractiveness Analysis By Product Type

Figure 11: North America Quadriplegia Care Devices Market Share Analysis (%) By Indication, 2021 & 2031

Figure 12: North America Quadriplegia Care Devices Market Y-o-Y Growth (%) By Indication, 2021-2031

Figure 13: North America Quadriplegia Care Devices Market Attractiveness Analysis By Indication

Figure 14: North America Quadriplegia Care Devices Market Share Analysis (%) By End User, 2021 & 2031

Figure 15: North America Quadriplegia Care Devices Market Y-o-Y Growth (%) By End User, 2021-2031

Figure 16: North America Quadriplegia Care Devices Market Attractiveness Analysis By End User

Figure 17: North America Quadriplegia Care Devices Market Share Analysis (%) By Country, 2021 & 2031

Figure 18: North America Quadriplegia Care Devices Market Y-o-Y Growth (%) By Country, 2021-2031

Figure 19: North America Quadriplegia Care Devices Market Attractiveness Analysis By Country

Figure 20: U.S Quadriplegia Care Devices Market Value Share, By Product Type (2021E)

Figure 21: U.S Quadriplegia Care Devices Market Value Share, By Indication (2021E)

Figure 22: U.S Quadriplegia Care Devices Market Value Share, By End User (2021E)

Figure 23: U.S Quadriplegia Care Devices Market Value (US$ Mn) 2021E and 2031F

Figure 24: U.S Quadriplegia Care Devices Market Value (US$ Mn) Analysis, 2016-2020

Figure 25: U.S Quadriplegia Care Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 26: U.S Quadriplegia Care Devices Market Attractiveness Analysis, By Product Type

Figure 27: U.S Quadriplegia Care Devices Market Attractiveness Analysis, By Indication

Figure 28: U.S Quadriplegia Care Devices Market Attractiveness Analysis, By End User

Figure 29: Canada Quadriplegia Care Devices Market Value Share, By Product Type (2021E)

Figure 30: Canada Quadriplegia Care Devices Market Value Share, By Indication (2021E)

Figure 31: Canada Quadriplegia Care Devices Market Value Share, By End User (2021E)

Figure 32: Canada Quadriplegia Care Devices Market Value (US$ Mn) 2021E and 2031F

Figure 33: Canada Quadriplegia Care Devices Market Value (US$ Mn) Analysis, 2016-2020

Figure 34: Canada Quadriplegia Care Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 35: Canada Quadriplegia Care Devices Market Attractiveness Analysis, By Product Type

Figure 36: Canada Quadriplegia Care Devices Market Attractiveness Analysis, By Indication

Figure 37: Canada Quadriplegia Care Devices Market Attractiveness Analysis, By End User

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate